Open Beta
TREN
MetriLume
TREN

US marketsPBYI

SEC-sourced researchBeta

PBYI

PUMA BIOTECHNOLOGY, INC.

Company comparison ↗

Data passport

CIK
0001401667
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Oct 6, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 235,637,000.0000 USD; December 2024: 230,468,000.0000 USD; December 2025: 228,371,000.0000 USD235.6M USD0 USD0December 2023December 2024December 2025
PBYI · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2023235,637,000.0000Feb 26, 2026
December 2024230,468,000.0000Feb 26, 2026
December 2025228,371,000.0000Feb 26, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025228,371,000.000031,111,000.000041,802,000.0000216,302,000.000085,962,000.0000Feb 26, 2026
December 2024230,468,000.000030,278,000.000038,918,000.0000213,333,000.0000121,208,000.0000Feb 26, 2026
December 2023235,637,000.000021,591,000.000027,009,000.0000——Feb 26, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$228.37MDecember 2025Feb 26, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$230.47MDecember 2024Feb 26, 202610-K
Net incomeNetIncomeLoss$31.11MDecember 2025Feb 26, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$41.8MDecember 2025Feb 26, 202610-K
Total assetsAssets$216.3MDecember 2025Feb 26, 202610-K
Total liabilitiesLiabilities$85.96MDecember 2025Feb 26, 202610-K

New filings

Explore methodology ↗